Skip to content

Amprius Technologies AMPX Warrants and Rights Outstanding

Warrants and Rights Outstanding at other companies

Nuvation Bio logo
Nuvation BioNUVB
5.8M0.0%
KEE
Keel Infrastructure Corp. Common StockKEEL
2.2M
NuScale Power logo
NuScale PowerSMR
0-100%
The RealReal logo
The RealRealREAL
7.9M
Calumet, Inc. logo
Calumet, Inc.CLMT
$7.8M0.0%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
312.5K0.0%

Other financials

Income statement

See full
Revenue$28.5M+153%
Gross profit$5.7M+343%
Operating income-$6.7M+30.9%
Net income-$5.0M+46.2%
EPS (diluted)-$0.04+50.0%

Balance sheet

See full
Cash & equivalents$62.6M+25.5%
Total debt$6.6M-82.6%
Total equity$109.4M+55.4%
Total assets$130.8M+10.4%

Cash flow

See full
Operating cash flow-$37.3M-164%
CapEx$980.0K+7.3%
Free cash flow-$38.3M-154%

Valuation

See full
Market cap$1.77B+631%

Profitability

See full
Gross margin18.1%+10.5pp
Operating margin-48.4%-19.0pp
Net margin-44%-17.6pp
FCF margin-65.1%-19.6pp

Returns & leverage

See full
Return on equity-44.2%-11.4pp
Debt / equity0.1×-0.5×
Current ratio7.1×+2.4×

Where this comes from

Reported directly by Amprius Technologies in its filing.

Tagged under the XBRL concept us-gaap:ClassOfWarrantOrRightOutstanding.

The official record: Amprius Technologies’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amprius Technologies's warrants and rights outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amprius Technologies's warrants and rights outstanding?
Amprius Technologies (AMPX) reported warrants and rights outstanding of 18.6M in Q1 2026.
How has Amprius Technologies's warrants and rights outstanding changed year-over-year?
Amprius Technologies's warrants and rights outstanding decreased by 2.4% year-over-year, from 19M to 18.6M.
What is the long-term trend for Amprius Technologies's warrants and rights outstanding?
Over 2 years (2023 to 2025), Amprius Technologies's warrants and rights outstanding has grown at a -37.2% compound annual growth rate (CAGR), from 47.7M to 18.8M.